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1. Introduction  
The ocular surface is composed of the conjunctiva and the cornea. The conjunctiva is a 
mucous membrane which covers the globe and inner part of the eyelids. The morphology of 
conjunctival epithelial cells are nonkeratinized stratified epithelia which vary from cuboidal 
over the tarsus, to columnar in the fornices, to squamous epithelia on the globe. Goblet cells 
account for up to 10% of the basal cells of the conjunctival epithelia. The substantia propia of 
the conjunctiva consists of loose connective tissue. The cornea is a transparent, avascular 
tissue which acts as both the anterior eye wall and an optical media for light to enter the eye. 
The corneal epithelium layer is composed of stratified squamous epithelial cells and 
makeup about 5 % (0.05 mm) of the total corneal thickness. The corneal epithelial stem cells 
located at the basal layer of the limbal epithelia proliferate continuously and give rise to the 
superficial layer that subsequently differentiate into superficial cells. Regulation of cell 
growth and metabolism are critical to maintain an intact ocular surface and transparent 
cornea. 
Primary tumors of the conjunctiva and cornea can be grouped into two major categories: 
congenital and acquired. The acquired lesions are composed of a variety of neoplasms 
which originate from squamous epithelia, melanocytes, and lymphocyte cells. Tumors of 
squamous epithelium occupy a large spectrum of lesions, ranging from benign lesions like 
squamous papilloma, to precancerous lesions which are confined to the surface epithelium 
(intraepithelial neoplasia or dysplasia, previously known as Bowen’s disease). There are 
even more invasive squamous cell carcinomas that break through the basement membrane 
to the underlying substantria propia of the conjunctiva or corneal stroma.  
The term ocular surface squamous neoplasia (OSSN) was first described in 1995 by Lee and 
Hirst to denote a spectrum of neoplasm originate from squamous epithelium ranging from 
simple dysplasia to invasive squamous cell carcinoma(SCC), involving the conjunctiva, the 
limbus, and the cornea.(Lee & Hirst 1995) Similar to cancer of cervix, it has a relative high 
recurrence after treatment and may metastasize. This tumor is considered as a low grade 
malignancy but invasive lesion can spread to the globe or orbit. This chapter highlights the 
epidemiology, etiologies and related factors, clinical manifestations, diagnostic tools, and 
standard care of management of these tumors. Squamous papilloma is also included as 
some conjunctival papilloma may have dysplastic potential. 
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2. Epidemiology and pathogenesis 
OSSN is considered an uncommon disease with geographic incidences which vary from 0.2 
to 3.5 per 100,000, with greater frequency near the equator. (Lee & Hirst 1995) It is the most 
common ocular surface tumor in many series.(Lee & Hirst 1995; Shields et al. 2004; Shields 
& Shields 2004) Prior to HIV pandemic, OSSN was noted to occur predominantly in the 
elderly for whom it was the third most common oculo-orbital tumor after malignant 
melanoma and lymphoma. (Lee & Hirst 1995) This tumor is rare in the United States, with 
an incidence rate of 0.03 per 100,000 persons, although the rate was approximately 5-fold 
higher in males and Caucasians (Sun et al. 1997).  
Pathogenesis of OSSN has yet to be attributed to specific etiologic factors, the main 
associated factors being exposure to ultraviolet (UV) radiation, human papilloma virus 
infection, and human immunodeficiency virus (HIV) seropositivity. 
2.1 Ultraviolet-B 
Chronic exposure to UV–B radiation (290-320 nm) is an established cause of many eye 
diseases such as pingecular, pterygium, cataract, and age-related macular degeneration. 
(Taylor et al. 1992) Evidence from epidemiologic studies and worldwide cancer registries 
have confirmed that the incidence rate of OSSN increased with proximity to the equator, 
presumably from increased solar UV radiation. (Lee et al. 1994; Newton et al. 1996) One 
population-based cancer study found that the incidence of squamous cell carcinoma(SCC) 
of the eye declined by 49% for each 10 degree increase in latitude, falling from more than 
12 cases per million per year in Uganda, to less than 0.2 cases per million per year in the 
UK. The incidence of SCC decreased by 29% per unit reduction in UV exposure. (Newton 
et al. 1996) There is considerable evidence linking cutaneous malignancy and UV 
exposure. (English et al. 1997) These lesions occur predominantly in sun-exposured areas 
of the skin. Lesions of OSSN are often found at the corneal limbus in the interpalpebral 
area, where sun-exposure is greater. The corneal limbus is a transitional area, from the 
conjunctival to corneal epithelial, analogous to the squamocollumnar junction of the 
uterine cervix which is prone to dysplastic change. The role of limbal stem cells in 
development of OSSN is controversial. These cells are long-lived and have great potential 
to clonagenic division. OSSN may arise from dysfunction limbal stem cells and from 
mutagenic agents such as UV radiation leading to mutations in the P53 tumor suppressor 
gene, also known as TP53 gene. One pilot case-control study found that the TP53 
mutation was detected in 56% of cancer cases (SCC) and 14% of control. 50% of mutations 
were CC-TT transition which was a molecular signature of mutagenesis by solar UV rays. 
This prevalence was high compared to any cancer type (not exceed 6%), but matched that 
of skin cancer in subjects with xeroderma pigmentosum.(Ateenyi-Agaba et al. 2004) Solar 
elastosis was also found more frequently in pathological specimens from the conjunctival 
squamous cell neoplasia (53.3% of cases and 3.3% of controls). (Tulvatana et al. 2003) One 
immunohistochemical study showed that UV radiation may play a role as a stimulating 
agent in the expression of some proteolytic enzymes, such as matrix metalloproteinases 
(MMPs) and their tissue inhibitors (TIMPs), which are relevant to neoplasia. (Ng et al. 
2008) 
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2.2 Human papilloma virus 
Human papilloma viruses (HPV) are oncogenic viruses and their role in human cervical 
carcinoma is well-established, however, their role in OSSN is unclear. Nakamura 
demonstrated that 50% of squamous tumors of the ocular surface and lacrimal sac were 
associated with HPV. (Nakamura et al. 1997) Biopsy specimens together with analyses of 
archrival embedded tissue revealed that the low risk HPV type 6 and 11 were the most 
common types of viruses associated with conjunctival papilloma. (Sjo et al. 2007; Verma et 
al. 2008) The high risk HPV type 16 and 18 have also been demonstrated in conjunctival 
papilloma, however, both are commonly found in high grade dysplasia, or invasive 
squamous cell carcinoma of the conjunctiva. (Sjo et al. 2007; Verma et al. 2008) One study 
identified the DNA of HPV 16, 18, and mRNA from the E6 region, which represented active 
transcribed viruses from all specimens of conjunctival intraepithelial neoplasia by using the 
PCR technique (n = 10). (Scott et al. 2002)  
In contrast, several studies have failed to demonstrate HPV in malignant conjunctival 
epithelial tumors and suggested that HPV was not associated with malignant conjunctival 
lesions and posed other mechanism, such as UVB being more important to the etiology of 
these lesions. (Eng et al. 2002; Tulvatana et al. 2003; Sen et al. 2007; Manderwad et al. 2009) 
Thus, the association between HPV and OSSN is variable in different geographic areas, and 
perhaps depends on the method of detection used. (Eng et al. 2002; Sen et al. 2007; Guthoff 
et al. 2009; Manderwad et al. 2009)  
2.3 Human immunodeficiency virus 
OSSN is now recognized as an AIDS-related cancer and its incidence has increased with the 
HIV pandemic in Africa. (Porges & Groisman 2003) One study revealed that HIV was strongly 
associated with conjunctival squamous neoplasia in Africa with an odds ratio of 13 (HIV was 
positive in 71% of cases and 16% of controls). (Waddell et al. 1996) A case-control study of 
conjunctival SCC in Uganda demonstrated a 10 fold increased risk of conjunctival SCC in HIV-
infected patients. (Newton et al. 2002) These tumors occurred at an earlier age in HIV-infected 
individuals and was often more aggressive than immunocompetent patients. OSSN may be 
the primary or only apparent manifestation of HIV infection in sub-Saharan Africa. (Spitzer et 
al. 2008) SCC can also involve other non-ocular sites such as the oropharynx, cervix, and 
anorectum.(Jeng et al. 2007) One study from the US found that there was an increased 
prevalence of HIV among patients with CIN who were younger than 50 years of age. (Karp et 
al. 1996) A HIV/AIDS Cancer Match Registry Study in the USA, however, demonstrated that 
the risk of conjunctival SCC was elevated regardless of HIV category, CD4 lymphocyte count, 
and time relative to AID-onset. The risk was highest with age 50, Hispanic ethnicity, and 
residence in regions with high solar-UV radiation. (Guech-Ongey et al. 2008) Tissue analysis 
from OSSN specimens in HIV-1 patients identified multiple oncogenic viruses including HPV, 
EBV, and KSHV, suggested that these infectious agents may contribute to the development of 
this malignancy in HIV patients. (Simbiri et al. 2010) 
2.4 Immunosuppression 
Of note, OSSN shares some striking similarities to skin neoplasm. It is believed that 
localized immune suppression of the skin from sun damage may lead to increased 
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susceptibility to HPV infection, causing neoplasia. Additional risks have also been reported in 
immunosuppressed cancer patients and organ transplant patients. (Shelil et al. 2003; Shome et 
al. 2006) As well, there have been reports of OSSN after corneal grafts, which may partly be 
related to local immunosuppression, HPV, or possibly that neoplastic cells had been in the 
donor corneal epithelia at the time of transplantation. (Ramasubramanian et al. 2010) 
2.5 Others 
Other factors associated with this condition include old age, the male sex (Lee & Hirst 1995; 
Sun et al. 1997), and fair skin pigmentation (Lee et al. 1994; Sun et al. 1997), as well as heavy 
cigarette smoking (Napora et al. 1990), exposure to petroleum products (Napora et al. 1990), 
and some genetic conditions like xeroderma pigmentosum. The latter is an uncommon 
genetic disorder, where excessive reactivity to UV light-induced damage results in a more 
malignant course. It is common in early childhood with severe photosensitivity and 
photophobia. (Kraemer et al. 1987; Chidzonga et al. 2009) Long standing use of ocular 
prosthesis (Jain et al. 2010)and contact lens wear (Guex-Crosier & Herbort 1993) have also 
been implicated in the pathogenesis of OSSN, although evidence is scant.  
3. Clinical manifestations 
The clinical spectrum of OSSN varies from benign lesions like squamous papilloma, 
precancerous lesions like conjunctiva-corneal intraepithelial dysplasia (CCIN), carcinoma in 
situ, and invasive squamous cell carcinoma (SCC).  
3.1 Conjunctival papilloma 
Squamous papillomas are among the most common benign acquired lesions of the 
conjunctiva. There are two forms of conjunctival papilloma: pendunculated and sessile. Both 
have different etiology and clinical courses. A pedunculated conjunctival papilloma is a 
fleshy, exophytic mass with a fibrovascular core which gives rise to a stalk. (Fig.1) It often 
arises in the inferior fornix, but can be present on the tarsus or bulbar conjunctiva. This 
lesion is associated with HPV subtype 6 or 11 (Sjo et al. 2007), and often occurs in children. It 
can regress spontaneously, or may recur after surgical excision. 
 
Fig. 1. Penduculate conjunctival papilloma arising from upper palpebral conjunctiva. 
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A sessile papilloma is more typically found at the limbus and has a broad base. The 
glistening surface and numerous red dots resemble a strawberry. (Fig.2) In contrast, a sessile 
lesion usually occurs in adults and more prone to dysplastic change. This lesion is related to 
HPV subtype 16 or 18. The latter oncogenic virus strains are strongly associated with human 
cervical carcinoma. 
 
 
Fig. 2. A. Sessile mass arising from bulbar conjunctiva. B. Multiple papillomas involve skin 
of two fingers in the same patient. 
3.2 Conjunctival-corneal intraepithelial neoplasia 
The clinical symptoms are generally nonspecific, vary from asymptomatic to chronic 
irritation, redness, and varying degrees of visual involvement determine by the extension of 
lesions to the visual axis. Clinical patterns may be in a papilliform, as well as velvety, 
gelatinous, leukoplakic, nodular or even diffuse fashion. (Fig. 3-5) The lesions most 
commonly arise in the interpalpebral area of perilimbal conjunctiva, but are less common in 
the forniceal or palpebral conjunctiva. A white plaque (leukoplakia) may occur on the 
surface of the lesion, representing secondary hyperkeratosis, which results from squamous 
cell dysfunction. The conjunctival lesion is mobile with feeder vessels supplying the mass. 
These tumors may appear as slowly growing localized lesions that mimic benign 
conjunctival degenerations, and sometimes coexist with pterygia or pingecula. (Hirst et al. 
2009) Sometimes, the lesions can have pigmentation and masquerade as malignant 
www.intechopen.com
 Intraepithelial Neoplasia 40
melanoma. (Shields et al. 2008) (Fig.6) OSSN can be diffused or have bilateral involvement. 
(Fig.7) Corneal OSSN is usually an extension of conjunctival squamous neoplasia. Rarely, 
isolated corneal involvement has been reported with the potentially aggressive form. (Fig.8) 
Bowman’s layer usually is a barrier to invasive lesions. (Cha et al. 1993) 
 
 
 
 
 
Fig. 3. Conjunctival intraepithelial neoplasia is present as a nodular mass with foci of 
leukoplakia on the surface of the lesion. 
 
 
 
 
 
Fig. 4. Conjunctival-corneal intraepithelial neoplasia: a flat gelatinous mass with surface 
leukoplakia involves 2 quadrants of limbus. 
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Fig. 5. Corneal intraepithelial neoplasia involving 270 degrees of the limbus (note vascular 
tuffs present on the mass) 
 
Fig. 6. Conjunctival-corneal intraepithelial neoplasia presents as a nodular mass with 
papillomatous pattern and hyperpigmentation (note feeder vessels are present). 
      
Fig. 7. Bilateral conjunctival-corneal intraepithelial neoplasia in an HIV-infected patient.  
A. Pigmented lesion with fibrovascular fond arising at the limbus. B. Diffused, flat lesion 
involving 360 degrees of the limbus (note central corneal epithelia defect is present in the 
photograph). 
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Fig. 8. Corneal intraepithelial neoplasia is present as a flat grayish mass with a fimbriated 
border and surface keratinization. 
3.3 Squamous cell carcinoma 
Squamous cell carcinoma is the final stage of this tumor where dysplastic epithelial invade 
beyond the basement membrane to the conjunctival substantia propia or corneal stroma. 
Clinically, invasive squamous cell carcinoma is generally larger and more elevated than 
CIN. (Fig.9) In practice, it may not be possible to distinguish invasive squamous cell 
carcinoma from intraepithelial lesion or carcinoma in-situ by using clinical features alone. 
However, an advanced lesion or mass that is immobile and fix to the globe should be 
suspected as an invasive lesion. A long term neglected mass or incomplete excised mass can 
invade through the globe or orbit. (Fig.10) 
Local invasion is the most prevalent mechanism of tumor spread. Intraocular invasion may 
be associated with iritis, glaucoma, retinal detachment, or rupture of the globe. Metastases 
are rare, and the first site of extraocular involvement is regional lymph nodes.  
 
 
 
Fig. 9. Invasive squamous cell carcinoma involves two quadrants of conjunctiva and cornea 
(note papillary vascular pattern present on the mass with feeder vessels). 
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A rare variant of conjunctival squamous cell carcinoma is the mucoepidermoid carcinoma. 
Clinically, this tumor occurs in older patients and has a yellow globular cystic component 
due to the presence of abundant mucous-secreting cells within cysts. It tends to be more 
aggressive than the standard squamous cell carcinoma, thus deserves wider excision and 
closer follow-up. The spindle cell variant of squamous cell carcinoma is likewise aggressive. 
(Shields et al. 2007) 
 
 
 
 
 
Fig. 10. An advanced squamous cell carcinoma involves the entire cornea and conjunctival 
surface with protrusions of the mass onto the lower eyelid. 
4. Diagnosis and investigations 
There are several points to cover before reaching diagnostic and management planning for 
OSSN, including clinical and pathologic findings, as well as the extension and complications 
of the tumors. 
 Clinical feature of the lesion: morphology, size, site, surface, feeder vessels, and exact 
anatomical location whether it is conjunctival (move with conjunctiva when applying 
topical anesthesia with cotton tip applicator) or scleral involvement (fixed to the globe). 
 Assessment of extension of the lesions 
- Intraocular invasion: perform gonioscopy to assess the invasion angle of the tumor. 
(Fig.11) Dilated fundus examination should be done to assess the intraocular 
invasion. In cases with media opacity, B-scan ultrasonography is helpful to assess 
sclera and intraocular spread.  
- Orbital invasion: by using CT scans or MRI scans, the accuracy and extension of the 
mass can accurately assess for the orbital or anterior eye involvement. 
- Regional lymph node spread: it is critical to assess the regional lymph nodes 
(preauricular, submandibular and cervical lymph nodes) as part of the clinical 
examination. 
www.intechopen.com
 Intraepithelial Neoplasia 44
   
Fig. 11. Squamous cell carcinoma A. Diffused mass involves more than two quadrants of the 
limbus. B. Gonioscopic findings in the same eye show angle invasion by the mass. 
 Pathologic diagnosis 
Since clinical appearance alone may not differentiate intraepithelial from invasive 
lesions, the gold standard for definite diagnosis is tissue histology, which can be 
performed by incisional or excisional biopsy. For relatively small tumors ( 4 clock 
hours of limbal involvement or  15 mm basal diameter), excisional biopsy is generally 
preferred to incisional biopsy. Larger lesions can be approached by wedge or punch 
biopsy. Incisional biopsy is also appropriate for conditions that are ideally treated with 
topical chemotherapy, or other treatments, such as radiation. 
4.1 Histology 
Histologic features of OSSN can be classified according to the presence of dysplastic cells 
originating in the basal cell layers which extend toward the surface. There are various patterns 
of dysplastic changes, ranging from the small squamous cells with increased nuclear-to-
cytoplasmic (N/C) ratio, large squamous cells with hyperchromatic nuclei, and spindle cells 
bearing oval-shaped nuclei.  The dysplastic cells contain abnormal nuclei either with nuclear 
pleomorphism or anisonucleosis. In addition, mitotic figures are increased and gradually 
pushed upward to the surface along with the degree of dysplasia. Many mitotic figures are 
abnormal.  The histologic terms used to describe the OSSN include(Font et al. 2006): 
 Dysplasia: dysplastic epithelial lesions of the conjunctiva and cornea divides into three 
grades based on the thickness of intraepithelial involvement. Koilocytes are rarely 
identified but suggestive for HPV infection when encountered. The thickness of 
involvement can be estimated using Periodic acid-Schiff (PAS) stain to demonstrate the 
presence of glycogen in non-neoplastic superficial squamous cells. Moreover, 
proliferating cell nuclear antigen (PCNA), Ki-67 and p53 immunostaining as well as 
argyrophillic nucleolar organizer region (AgNOR) staining may be useful for grading 
the dysplastic lesions as well as for correlation with clinical morphologic findings. 
(Aoki et al. 1998) Grading of dysplasia is described as:  
 Mild – less than a third thickness of the epithelium is occupied by atypical 
cells.(Fig.12A) 
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 Moderate - within three quarters thickness of the epithelium is occupied by 
atypical cells. 
 Severe – nearly full thickness of the epithelium is occupied by atypical 
cells.(Fig.12B) 
 Carcinoma in situ: full-thickness epithelial neoplasia with loss of the normal surface 
layer. (Fig.12C) Arborizarion of the proliferating blood vessels and extension of 
connective tissue along the neoplastic area may mimic the sessile papilloma.(Pizzarello 
& Jakobiec 1978)  
 Invasive squamous cell carcinoma: the entire thickness of the epithelium has been replaced 
by the dysplastic cells and the basement membrane of the basal epithelial layer has been 
breached due to invasion of dysplastic cells into the substantia propia.  Formation of 
cancer cell nests and single cancer cells with bizarre nuclei in the stroma is definitive of 
invasive carcinoma.(Tunc et al. 1999) (Fig.12D) 
4.2 Cytology 
Ocular surface cytology can be performed by two major techniques:first is exfoliative 
cytology by using spatula scrapings or a cytobrush to collect the sample, and second is 
impression cytology by using the collecting devices to collect the sample by contact with the 
surface of the lesions. The cytologic features of OSSN have been reviewed by several 
authors.(Lee & Hirst 1995)  
 Dysplasia: Squamous cells with enlarged nuclei bearing fine to coarse granulation of the 
nuclear chromatins, irregular nuclear borders, scanty cytoplasm. The background is clean.  
 Carcinoma in situ: Variable numbers of dysplastic cells with an admixture of intact and 
well preserved malignant cells. They are variable in size with scanty cytoplasm, usually 
< 1 nuclear diameter in width. The enlarged nuclei displays neoplastic features of 
hyperchromatism, irregular nuclear membrane thickening, or crusting of nuclear 
membranes. The other nuclear features include abnormal clearing or condensation of 
nuclear chromatins and large acidophilic nucleoli. However, background of the smear 
is clean. 
 Invasive squamous cell carcinoma: Cytologic features of the SCC have been graded into 
two groups.  
- Grade 1-2: Marked cytologic aberration with bizarre malignant cell features 
including tadpole cells with cytolplasmic tails, fiber or spindle cells, 
hyperkeratinized cells with opaque refractile red or orange cytoplasm, and 
malignant nuclei.  
- Grade 3-4: Large or small cancer cells with scanty cytoplasm. Nonkeratinized cells 
maybe partially destructed cells, or complete loss of cytoplasm bearing large to 
huge pleomorphic nuclei. With deeper invasion and ulceration, tumor “diathesis” 
background- necrotic tumor cells, debris, blood, and leukocyte exudates are more 
prominent. 
The advantages of cytology are a simple technique in diagnosis and follow-up after 
treatment in OSSN, particularly for detection of recurrences. However, some problems have 
been reported in exfoliative cytology techniques which may include a degree of uncomfort 
for the patient, problems with drying artifacts, problems with cellular overlap (difficult to 
interpret the specimens reliably) and non-localized lesions. 
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Impression cytology (IC) is a technique for collecting the superficial layers of the ocular 
surface by applying collecting devices. Commonly used are cellulose acetate filter paper 
with a pore size ranging from 0.025 – 0.45 micron or other materials (nitrocellulose filters, 
Biopore membranes, or polyether sulfone filters)(Calonge et al. 2004) so that cells adhere to 
the surface of the device and can be removed and processed further for analysis by a 
diversity of methods. IC represents a simple and non-invasive technique for both diagnosis 
and follow-up after treatment of several disorders of the ocular surface. The main 
advantages are that it allows relatively easy collection of epithelial samples with minimal  
 
 
 
 
Fig. 12. Histologic features. A. Mild dysplasia; the basal cells are disordered with increased 
nuclear sizes and coarse nuclear chromatin. B. Severe dysplasia; the epithelial cells are 
varied in shapes and sizes with large pleomorphic nuclei.  The surface cells are flattened 
with pyknotic nuclei. C. Carcinoma in situ: the entire thickness of the epithelium is 
composed of dysplastic cells bearing pleomorphic nuclei. Note the inflammatory reaction in 
the stroma. D. Invasive squamous cell carcinoma; the invasive nest in the stroma is 
composed of bizarre cells similar to those in the epithelium.  The nuclei are plemorphic with 
thick nuclear membranes and prominent nucleoli (Hematoxylin and Eosin stain. Original 
magnification X40)  
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discomfort to the patient, can be performed on an outpatient basis, and allows more precise 
localization of the area being studied. In addition, a cell to cell relationship can be assessed, 
which allows one to see cells the way they exist in vivo.  
Successful results of IC in diagnosis of OSSN in histologic-confirmed cases have been 
reported, with positive results of 77% - 80% of the cases.(Nolan et al. 1994; Tole et al. 2001) 
One study of ocular surface tumors found that IC had a positive and negative predictive 
value of 97.4% and 53.9%, respectively, when compared to histology.(Tananuvat et al. 2008) 
The limitations of IC are that, first, IC may be less sensitive for cases with keratotic lesions, 
because keratotic lesions are common in OSSN (68%) compared with a much lower 
incidence in cervical cancer. Second, IC may not distinguish carcinoma in situ from 
minimally invasive disease, because only the superficial cells are collected in the IC method. 
Therefore, a tissue biopsy remains necessary in cases with negative cytology.  
At present, no cytologic criteria have been identified that reliably differentiate invasive 
carcinoma from in situ in IC samples. Squamous cell abnormalities may be classified into 4 
groups, using a modification of the Bethesda system in cervical cytology(Solomon et al. 
2002): (1) atypical squamous cells (ASC) (Fig.13 B); (2) low grade squamous intraepithelial 
lesions (LSIL), which encompass squamous papilloma and mild dysplasia(Fig.13 C); (3) high 
grade squamous intraepithelial lesions (HSIL), which encompass moderate to severe 
dysplasia and carcinoma in situ (CIS) (Fig.13 D-E); and (4) squamous cell carcinoma 
(SCC).(Fig.13 F) One series of OSSN found that SCC from cytology had a highest rate of 
correlation(91.7%) with histology followed by HSILs (45.5%), ASCs(42.9%),normal epithelia 
(33%), and LSILs (21.4%), respectively.(Tananuvat et al. 2008) Barros and coworkers used a 
scoring index modified from the Bethesda system which revealed a predictive index score of 
4.5 represented the best cut-off point for diagnosis of SCC by using IC with a sensitivity of 
95%, specificity of 93%, positive predictive value of 95%, and a negative predictive value of 
93%.(Barros et al. 2009) However, the skill and the experience of cytologist are necessary for 
interpretation of the IC specimens. 
4.3 Immunohistochemical analysis: Ki-67 proliferative index 
Ki-67 nuclear antigen is expressed in all phases of the cell cycle, except the G0 phase. Ki-67 
immunohistochemical analysis has been applied in the histopathologic diagnosis of 
malignant tumors. In normal cervical squamous mucosa, Ki-67 positive cells are found 
mainly in the parabasal layer. In cervical squamous intraepithelial lesions (SILs), the number 
of Ki-67 positive cells increased as the cell grading went from normal to low grade SIL(LSIL) 
to high grade SIL(HSIL). Similar findings have been reported in case of conjunctival SCC 
and intraepithelial neoplasia. One study compared tissue specimens obtained from SCC, 
CIN, and non-CIN (pterygium) lesions, revealed that Ki-67 proliferative index (Ki-67 PI) 
was significantly higher in SCC and CIN than in pterygium.(Ohara et al. 2004) In another 
study, the Ki-67 PI of CINs accounted for 20-48% which was significantly higher than non-
CIN lesions (8-12%) and normal conjunctivae (8-12%). This study also showed that there 
was no statistical significance of P53-positive cells in CIN lesion compared to non-CIN 
lesions and normal conjunctiva due to the wide standard deviations. (Kuo et al. 2006) 
Therefore, Ki-67 PI may serve as a meaningful diagnostic marker for OSSN. 
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Fig. 13. Cytologic features from impression cytology specimens. A. Normal squamous cells 
with small nuclei and fine keratohyaline granules. B. Atypical cells with increased nuclear-
to-cytoplasmic (N/C)ratio and glassy cytoplasm. C. Low grade corneal intraepithelial 
lesion; the dysplastic cells are varied in sizes with increased N/C ratio. They are similar to 
basal cells. Large polygonal squamous cells with small nuclei are also included. D. High 
grade corneal intraepithelial lesion; the nuclei are pleomorphic with coarse nuclear 
chromatins. E. High grade corneal intraepithelial lesion with inflammatory exudates on the 
background. The dysplastic cells cluster together with pleomorphic nuclei. F. Squamous cell 
carcinoma. The small and spindle cancer cells are aggregated together with the 
inflammatory background. Nuclear details are hardly noted as the cells overlap one another. 
(Papanicolaou stain. Original magnification X40)  
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4.4 Other investigation tools 
Recently, in vivo confocal microscopy has proved useful as a noninvasive technique to 
investigate various ocular surface lesions including OSSN.  Two studies found that confocal 
microscopic findings highly correlated with histologic features in CIN, thus provided real-
time monitoring of the condition during treatment. (Alomar et al. 2011; Parrozzani et al. 
2011)When compared to histology, however, there were some limitations. First, confocal 
microscopy provides en face images of cells compared to cross-sectional images from tissue 
histology. Second, fixation process required for histology results in shrinkage of tissue, 
therefore, morphometric comparison between living and fixed tissue have to be viewed in 
this context. Third, it is difficult to obtain in vivo confocal microscopic images and histologic 
images from exactly the same site of the tissue being examined. 
The ultra high resolution (UHR) optical coherence tomography (OCT), a novel diagnostic 
technique for assessment of anterior eye segment lesions, was used for diagnosis and follow 
up after treatment of conjunctival-corneal intraepithelial neoplasia (CCIN) in a prospective 
case series. The UHR OCT images correlated well with the histologic specimens obtained 
from incisional biopsy before treatment. The UHR OCT was able to detect residual disease 
that was clinically invisible. The limitation of this machine was its capability to detect 
microinvasive lesions because the resolution of the current UHR OCT is approximately 2 
micron, thus could not detect intracellular features. (Shousha et al. 2011) 
Differential diagnosis 
Because of the noninvasive nature of OSSN, the diagnosis is often missed or delayed. The 
patients’ symptoms are sometimes treated as chronic conjunctivitis. Other conditions that 
are commonly mistaken include pterygium, pingecular, corneal pannus, viral 
keratoconjunctivitis, and corneal dystrophy.  
5. Management 
5.1 Conjunctival papilloma 
Many conjunctival papilloma regress spontaneously. A pedunculated papilloma that is 
small, cosmetically acceptable and asymptomatic may be observed, although it may take 
months to years for spontaneous resolution. Larger and more peduculated lesions are 
generally symptomatic and of poor cosmetic acceptance, thus surgery adjunct with 
cryotherapy is recommended.  A sessile papilloma must be observed closely. If there is any 
evidence of dysplastic change, excision with cryotherapy should be preformed.  
Complete excision without manipulation of the tumor (no touch technique) is a crucial part 
of the surgical excision to minimize the risk of the virus spreading to uninvolved healthy 
conjunctiva. Double freeze-thaw cryotherapy is applied to the remaining conjunctiva to 
prevent tumor recurrence. An incomplete excision can stimulate growth and lead to a 
recurrence of the lesion and a worse cosmetic outcome. (Fig.14) Topical interferon- alpha 2b 
(Schechter et al. 2002; Kothari et al. 2009) and mitomycin C(Hawkins et al. 1999; Yuen et al. 
2002) have been employed in the treatment of conjunctival papilloma. Immunomodulating 
agents such as oral cimetidine have led to regression of viral related papilloma. (Chang & 
Huang 2006) 
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Fig. 14. Multifocal recurrence conjunctival papillomas involving lower palpebral 
conjunctiva, fornix, canruncle, and lower punctum after two previous excisions. 
5.2 Preinvasive and invasive squamous neoplasia 
5.2.1 Surgery 
The management of OSSN varies with the extent of the lesion. The most accepted method of 
OSSN remains complete surgical excision. However, residual tumor cells left at the 
bordering tissue can induce tumor recurrence. Adjuvant therapies such as cryotherapy, 
alcohol abrasion, or topical agents are used in order to absolutely eradicate tumor cells from 
the ocular surface. Thus, the main treatment strategy is complete excision of the tumor with 
a wide surgical free margin followed by double freeze-thaw cryotherapy at the conjunctival 
margin and alcohol epitheliectomy for the corneal component. In case the tumor is adherent 
to the globe, a thin lamella of underlying sclera should be removed. 
In order to decrease the chance of tumor recurrence, the standard surgical technique should 
be emphasized in all cases. The “no touch” technique purposed by Shield et al (Shields et al. 
1997) is a widely accepted surgical approach as the conjunctival components, along with 
Tenon’s fascia, should be excised with minimal manipulation of the tumor because cells 
from these friable tumors can seed into adjacent tissue. In addition, the surgery should be 
performed using microscopic techniques and the operative field should be left dry until 
after the tumor is completely removed to minimize spreading of tumor cells. Cryotherapy is 
thought to act through its direct destructive effects on cells, as well as the obliteration of 
microcirculation in the areas treated, resulting in ischemic infraction of the abnormal tissue. 
This is performed by freezing the surrounding bulbar conjunctiva as it is lifted away from 
the sclera using the cryoprobe. When the ice ball reaches the size of 4-5 mm, it is allowed to 
thaw and the cycle repeated. The complications that may occur from misuse of this 
technique or when the globe is accidentally frozen include cataract, uveitis, sclera and 
corneal thinning, and phthisis bulbi. 
In cases of advanced tumors, the large conjunctival defect created by excision , particularly 
those over 4 clock hours, often require tissue replacement from a transpositional 
conjunctival flap, a free conjunctival autograft from the opposite eye, buccal mucosa graft, 
or amniotic membrane transplantation.  
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However, OSSN can be diffused or multifocal, with borders that are difficult to detect 
clinically, and there is also a chance for skipped areas from histopathologic examination. 
Reported recurrence rate after surgical treatment is significant (range between 15%-52%). 
(Lee & Hirst 1995; Tabin et al. 1997; Sudesh et al. 2000; McKelvie et al. 2002) Incomplete 
excision with positive surgical margins has been identified as a major risk factor for 
recurrence. (McKelvie et al. 2002) The more severe grades of OSSN appear to recur at higher 
rates. With adjunctive cryotherapy, the recurrent rate appears to be reduced (from 28.5% 
and 50% after simple excision, to 7.7% and 16.6% after excision with cryotherapy in primary 
and recurrence OSSN, respectively). (Sudesh et al. 2000)  
The drawbacks of surgical treatment are complications resulted from the healing process, 
particularly in advanced lesions, including tissue granulation, symblepharon, 
pseudopterygium, diplopia from tissue shortening, blepharoptosis, limbal stem cell 
deficiency, and other complications. These surgical problems instigate further investigation 
into safer, alternative treatments.  
5.2.2 Chemotherapy 
Due to the relatively high rate of recurrence after surgical excision, various topical 
treatments have been advocated as a sole therapy for OSSN. Topical therapy offers a 
nonsurgical method for treating the entire ocular surface with less dependence on defining 
the tumor margin, potentially eliminating subclinical lesions. Topical treatment can offer a 
high drug concentration, avoiding systemic side effects. Furthermore, the increased cost, 
stress, pain, and trauma associated with surgical procedures are avoided. Topical 
medications have been used effectively for treating this condition comprised of mitomycin C 
(MMC), 5-fluorouracil (5-FU), and interferon, with MMC used most commonly by a group 
of external disease specialists. (Stone et al. 2005) These agents have been used as a sole 
therapy or a surgical adjuvant (preoperatively, intraoperatively, and postoperatively) for 
treatment of OSSN. 
Mitomycin C 
Mitomycin C (MMC) is an ankylating antibiotic that binds to DNA during all phases of the 
cell cycle leading to irreversible cross-linking and inhibition of nucleotide synthesis. When 
applied to conjunctival surfaces as a surgical adjunct, MMC has been shown to inhibit 
fibroblast cell migration, decrease extracellular matrix production, and to induce apoptosis 
in Tenon’s capsule fibroblast. It is well known that chronic tissue effects from topical MMC 
administration can persist for many years after cessation of the treatment, thereby 
mimicking the effect of ionizing radiation. (McKelvie & Daniell 2001)  
MMC has been widely used in glaucoma and pterygium surgery for its anti-fibrotic effect on 
subconjunctival fibroblast. The use of MMC for treatment of OSSN was first described in 
1994.(Frucht-Pery & Rozenman 1994) Since then several case series using different 
concentrations and durations have been published. Common protocol ranges from topical 
MMC 0.02%-0.04% given four times a day to the affected eye for 7 to 28 days.(Fig.15) One 
case series demonstrated that even a smaller concentration of 0.002% of MMC was effective 
in treatment of primary and recurrent OSSN. (Prabhasawat et al. 2005) Several studies 
(similar to those used in fractionation of radiation in treatment of systemic cancers) 
preferred a cycle of 7 days in alternate weeks (1 week on and 1 week off) to allow cells of the 
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ocular surface to recover/repair. (McKelvie & Daniell 2001; Shields & Shields 2004) One 
randomized control trial found that MMC 0.04% eye drops used 4 times a day for 3 weeks 
was effective and caused early resolution of noninvasive OSSN. A relative resolution rate in 
MMC versus placebo was 40.87 and the mean time for tumor resolution in this study was 
121 days, and there was no serious complication in midterm follow-up. (Hirst 2007) MMC 
has also been used as a surgical adjunct for OSSN: preoperative, to decrease the size of the 
extensive lesions before surgical excision (chemoreduction), intraoperative, and 
postoperative to decrease recurrences.(Kemp et al. 2002; Chen et al. 2004; Gupta & Muecke 
2010) 
 
Fig. 15. Severe corneal intraepithelial neoplasia treated with mitomycin C 0.02% four times 
daily, alternating weeks: A. Appearance before treatment; B. Lesion partially resolved two 
months after treatment ; C. Completely resolved mass three months after treatment; D. 
Cornea is clear without recurrence eight years later. 
Reported complications of MMC in treatment of OSSN included conjunctival hyperemia, 
punctuated epithelial erosion, and keratoconjunctivitis. A large retrospective series (n= 100 
eyes) of ocular surface tumors treated with topical MMC 0.04% revealed that allergic 
reaction and punctual stenosis were two common complications. (Khong & Muecke 2006) 
Some of these side effects can be managed by stopping the medication and adding topical 
steroid three to four times daily. No significant changes were found on corneal endothelial 
cells after treatment with topical MMC 0.04% in a cyclic manner. (Panda et al. 2008) 
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However, MMC was found to have deleterious effects on endothelium cells after pterygium 
surgery, thus its judicious use and long term follow-up are mandatory.(Bahar et al. 2009) 
Even though common side effects related to topical MMC are self-limited, limbal stem cell 
deficiency appeared to be a significant long-term complication. (Dudney & Malecha 2004; 
Russell et al. 2011) Mckelvie and coworker reported the effects of MMC in treatments of 
OSSN on impression cytology; MMC appeared to produce cell death by apoptosis and 
necrosis. Cellular changes related to MMC mimic those caused by radiation-cytolmegaly, 
nucleomegaly, and vacuolation. These changes may persist at least 8 months after cessation 
of MMC therapy. (McKelvie & Daniell 2001) MMC-induced long term cytologic changes on 
the ocular surface have been demonstrated in another study. (Dogru et al. 2003) Serious 
complications of MMC such as scleromalacia, corneal perforation, cataract, glaucoma, and 
anterior uveitis have been reported in pterygium treatment and should be of concern if this 
agent is used in an open conjunctival wound or used excessively.(Rubinfeld et al. 
1992)(Fig.16) 
When MMC is prescribed as a treatment for OSSN, certain precaution should be taken. 
Patients and their families are advised to carefully handle the medication. Pregnant women 
and young children should avoid direct contact with the medication. Patients should be 
instructed to close their eyes for at least 5 minutes after instillation of MMC or punctal plugs 
are placed in both superior and inferior puncta to avoid nasolacrimal and systemic 
absorption of the drug. Since MMC is a chemotherapeutic agent, all residual bottles should 
be returned to the pharmacy for proper disposal. 
 
Fig. 16. A. Scleritis in eye with conjunctival intraepithelial neoplasia after excisional biopsy 
and postoperative mitomycin C. B. Scleral thinning in the same eye one year later after 
scleritis resolved. 
5-Fluorouracil  
Similar to MMC, topical 5-fluorouracil (5-FU) has been used to inhibit subconjunctival 
fibroblasts in glaucoma surgery. 5-FU is an antimetabolite used to treat many epithelial 
cancers because of its rapid action on rapidly proliferating cells. It acts by the inhibition of 
thymidylate synthetase during the S phase of the cell cycle, preventing DNA and RNA 
synthesis in rapidly dividing cells because of a lack of thymidine. Pulse 1% topical 5-FU in 
cycle of 4 days “on” followed by 30 days “off” until resolution of the lesion was a well-
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tolerated and effective method in treatment of OSSN, alone or as an adjunct to excision or 
debulking therapy. (Yeatts et al. 2000; Al-Barrag et al.; Parrozzani et al.; Rudkin & Muecke) 
Local side effects associated with topical 5-FU, such as lid toxicity, superficial keratitis, 
epiphora, and corneal epithelial defect have been reported. (Rudkin & Muecke 2011)  By 
using confocal microscopy, there was no long-term corneal toxicity associated with 1% 
topical 5-FU compared to the controlled eye. (Parrozzani et al. 2011)The advantages of this 
agent are its few side effects, plus the medication is inexpensive, easy to handle by both 
medical personnel, as well as the patients. 
Interferon 
Interferons (IFN) are a group of proteins that bind to surface receptors of target cells, 
triggering a cascade of intracellular antiviral and antitumor activities. Systemic interefon-
alpha has been used in treatment of hairy cell leukemia, condyloma acuminate, Karposi’s 
sarcoma in AIDS, and hepatitis (both B and C). Recombinant topical IFN-2b (1 million 
IU/ml) 4 times a day has been used effectively in treatment of primary OSSN. (Sturges et al. 
2008) The antiviral effects of IFN-2b may explain why it may be less effective as a primary 
treatment for lesions not linked to HPV infections. Topical IFN-2b has been used 
effectively in management of recurrent or recalcitrant lesions where surgical excision or 
MMC have failed. (Holcombe & Lee 2006) This agent is well tolerated and does not 
markedly damage the limbal stem cells. Subconjunctival/perilesional IFN--2b (1-3 million 
IU/ml) has also been used effectively for treatment of both primary and recurrent OSSN. 
(Nemet et al. 2006; Karp et al. 2010) Topical instillation of IFN appears to be associated with 
few side effects, such as follicular conjunctivitis and conjunctival injections, which appeared 
to completely resolve after cessation of the medication. (Schechter et al. 2008) There was a 
report of corneal epithelial microcyst after topical administration interferon identical to that 
which had been reported with systemic interferon therapy. (Aldave & Nguyen 2007) 
Subconjunctival IFN-2b has been associated with transient fever and myalgias , similar to 
systemic applications. 
Topical chemotherapeutic agents have demonstrated acceptable efficacy in treatment of 
OSSN. Comparison of these three drugs for treatment of noninvasive OSSN reveals that 
MMC is the most effective (88%), followed by 5-FU(87%), and IFN-2b (80%). MMC has the 
highest rate of side effects, perhaps because MMC is the most frequently used topical agent. 
IFN-2b is the least toxic, however, it is the costliest of the three agents. (Sepulveda et al. 
2010) The relative indications of using topical treatments in OSSN are: 1) >2 quadrants 
conjunctival involvement, 2) > 180 degree limbal involvement, 3) extension into the clear 
cornea involving the papillary axis, 4) positive margin after excision, and 5) patient unable 
to undergo surgery. (Sepulveda et al. 2010) However, some clinicians prefer surgical 
excision as an initial treatment of invasive lesions if the extension is less than 6 clock hours 
of involvement, because this provides confirmation of the diagnosis with little cosmetic 
disfigurement if properly performed.(Shields et al. 2002) When topical agents are considered 
as a treatment regimen of OSSN, they should be used with caution as long-term effects on 
the ocular surface of the eye, as well as the adjacent eyelids and nasolacrimal drainage 
system, have not yet been completely defined. 
Other treatment modalities in management of OSSN include plaque brachytherapy with 
Iodine-125 (Walsh-Conway & Conway 2009), beta-radiation therapy, gamma radiation, and 
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immunotherapy with dinitrochlorobenzene (DNCB). (Lee & Hirst 1995) Aggressive 
treatments such as enucleation or exenteration are considered in cases with ocular or orbital 
invasion. (Shields & Shields 2004) 
6. Clinical course 
OSSN is a slow growing tumor; however in neglected cases it can invade the globe and orbit 
and may lead to death. It has a potential for recurrence after treatment. In a series of OSSN, 
both intraepithelial and invasive lesions, it was found that sclera involvement occurred in 
37%, orbital invasion 11%, and no metastasis or death was related to the tumors. (Tunc et al. 
1999) In a series of 26 conjunctival SCC, intraocular invasion occurred in 11% of the patients, 
corneal or sclera involvement 30%, and orbital invasion 15%. Exenteration was required in 
23% of cases, and 8% died of metastatic diseases. (McKelvie et al. 2002) Predicting factors 
related to significantly increased tumor recurrence include old age, large diameter lesions, 
high proliferation index (Ki-67 score), and positive surgical margin. (McKelvie et al. 2002) 
A long-term study of CCIN also found that the recurrence rate after surgery was higher in 
cases with positive surgical margins than those with free margins (56% versus 33%). Timing 
for recurrence ranged from 33 days to 11.5 years after primary treatment, and those with 
incomplete excision recurred earlier than those with free margins. (Tabin et al. 1997) The 
slow growth of recurrent tumors and evidence of late recurrence 10 years after surgery 
warranted the need to have annual patient follow-ups for the remainder of their lives.  
OSSN in immunosuppressed individuals seem to have an aggressive course in contrast to a 
relatively benign clinical course in classic OSSN.(Masanganise & Magava 2001; Gichuhi & 
Irlam 2007) The tumors often grow rapidly and have a tendency to invade the globe or orbit. 
This problem is exacerbated by poor health care facilities, and patient compliance, which are 
often present in HIV endemic areas. Management with standard approaches with these 
patients is often associated with higher rates of recurrence and intraocular or orbital 
invasion. Thus, treatment regimens may need a wide excision with a histological analysis of 
the margin, as well as other adjuncts such as cryotherapy, topical chemotherapeutic agents 
to prevent local recurrence, intraocular or orbital invasion, and metastasis. In addition, it is 
crucial for every HIV patient to have a detailed eye examination at presentation and 
maintain a close follow-up to detect recurrent disease early in its course. 
7. Conclusion 
OSSN is a spectrum of diseases ranging from simple dysplasia to invasive carcinoma. This 
lesion is considered a low grade malignancy, but its invasive counterpart can spread to the 
globe or orbit. It is the most common ocular surface tumor and its incidence varies in 
different geographic locations. The main risk factor is UV-B exposure as its incidence 
increases in areas close to the equator. Other important risk factors are the human papilloma 
virus and human immunodeficiency virus. However, it is unclear whether host factors (e.g. 
genetic factors and HIV-related immune impairment) or characteristics of the ocular surface 
epithelia may also be part of the etiopathogenesis of OSSN. Symptoms range from none at 
all to severe pain or visual loss. Clinically, these tumors most commonly arise in the 
interpalpebral area, particularly at the limbal region. Early diagnosis and management 
decrease the risk of locally aggressive and can improve the patients’ prognosis for local 
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control and preservation of vision. In clinical practice, OSSN is generally evaluated by tissue 
histology. The developments of pre-operative diagnostic techniques such as impression 
cytology are of value in diagnosis and follow-up after treatment. Surgical excision adjunct 
with cryotherapy combined with alcohol abrasion in cases of corneal involvement are the 
main treatment strategy. Recurrence rates are higher for more severe grades of OSSN and 
have been related to the adequate of surgical margins at the initial excision. The standard 
management care of OSSN appears to shift toward topical chemotherapy such as MMC, 5 
FU, and interferon as a sole therapy, or a surgical adjunct, particularly in diffused or un-
operable cases. These alternative treatments continue to evolve despite a paucity of long 
term results in published literature. Invasive disease may cause intraocular or orbital 
involvement with eye loss, and occasionally may lead to death. Recurrence after initial 
treatment is variable and warrants life-long follow-up in all case of OSSN.  
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